autologous neo-kidney augment
Cell therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2013 (NCT02008851)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous neo-kidney augment
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02836574 | Phase 2 | Sep 1, 2016 | CTI Clinical Trial and Consulting Services, Johns Clinical Consulting, RegenMed |
| NCT02525263 | Phase 2 | Jul 1, 2016 | CTI Clinical Trial and Consulting Services, RegenMed |
| NCT02008851 | Phase 1 | Dec 1, 2013 | RegenMedTx |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CTI Clinical Trial and Consulting Services | For profit | 2 | 0 | 1 | 2016 |
| RegenMed | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Johns Clinical Consulting | For profit | 1 | 0 | 1 | 2016 |
| RegenMedTx | For profit | 1 | 1 | 1 | 2013 |
4 organizations
Page 1 / 1